REMEGEN CO. LTD YC 1 - Asset Resilience Ratio

Latest as of December 2025: 16.77%

REMEGEN CO. LTD YC 1 (REG) has an Asset Resilience Ratio of 16.77% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. For the complete balance sheet picture, see balance sheet size of REMEGEN CO. LTD YC 1.

Liquid Assets

€1.22 Billion

≈ $1.42 Billion USD Cash + Short-term Investments

Total Assets

€7.25 Billion

≈ $8.47 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2025–2025)

This chart shows how REMEGEN CO. LTD YC 1's Asset Resilience Ratio has changed over time. Read debt load of REMEGEN CO. LTD YC 1 for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down REMEGEN CO. LTD YC 1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. See REMEGEN CO. LTD YC 1 (REG) liquidity interval to measure how many days the company can operate on defensive assets alone.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.22 Billion	16.77%
Total Liquid Assets	€1.22 Billion	16.77%

Asset Resilience Insights

Good Liquidity Position: REMEGEN CO. LTD YC 1 maintains a healthy 16.77% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

REMEGEN CO. LTD YC 1 Industry Peers by Asset Resilience Ratio

Compare REMEGEN CO. LTD YC 1's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyundai Bioscience Co. Ltd KQ:048410	Biotechnology	22.98%
CSL Ltd AU:CSL	Biotechnology	0.41%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Hualan Biological EngineeringInc SHE:002007	Biotechnology	14.68%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	2.81%

Annual Asset Resilience Ratio for REMEGEN CO. LTD YC 1 (2025–2025)

The table below shows the annual Asset Resilience Ratio data for REMEGEN CO. LTD YC 1.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	16.77%	€1.22 Billion ≈ $1.42 Billion	€7.25 Billion ≈ $8.47 Billion	--

pp = percentage points

About REMEGEN CO. LTD YC 1

F:REG Germany Biotechnology

Market Cap

$2.07 Billion

€1.77 Billion EUR

Market Cap Rank

#6087 Global

#919 in Germany

Share Price

€8.50

Change (1 day)

-2.34%

52-Week Range

€7.14 - €13.50

All Time High

€13.60